Constitutive/hypoxic degradation of HIF-α proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein

被引:62
|
作者
Kong, Xianguo
Alvarez-Castelao, Beatriz
Lin, Zhao
Castano, Jose G.
Caro, Jaime
机构
[1] Thomas Jefferson Univ, Cardeza Fdn, Philadelphia, PA 19107 USA
[2] UAM, Fac Med, CSIC, Dept Bioquim, Madrid, Spain
[3] UAM, Inst Invest Biomed Alberto Sols, CSIC, Fac Med, Madrid, Spain
关键词
D O I
10.1074/jbc.M700704200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional activator complex HIF-1 plays a key role in the long term adaptation of cells and tissues to their hypoxic microenvironment by stimulating the expression of genes involved in angiogenesis and glycolysis. The expression of the HIF-1 complex is regulated by the levels of its HIF-alpha subunits that are degraded under normoxic conditions by the ubiquitin-proteasome system. Whereas this pathway of HIF-alpha protein degradation has been well characterized, little is known of their turnover during prolonged hypoxic conditions. Herein, we describe a pathway by which HIF-1 alpha and HIF-2 alpha proteins are constitutively degraded during hypoxia by the proteasome system, although without requirement of prior ubiquitylation. The constitutive/hypoxic degradation of HIF-alpha proteins is independent of the presence of VHL, binding to DNA, or the formation of a transcriptionally active HIF-1 complex. These results are further strengthened by the demonstration that HIF-alpha proteins are directly degraded in a reconstituted in vitro assay by the proteasome. Finally, we demonstrate that the persistent down-regulation of HIF-1 alpha during prolonged hypoxia is mainly caused by a decreased production of the protein without change in its degradation rate. This constitutive, ubiquitin-independent proteasomal degradation pathway of HIF-alpha proteins has to be taken into account in understanding the biology as well as in the development of therapeutic interventions of highly hypoxic tumors.
引用
收藏
页码:15498 / 15505
页数:8
相关论文
共 50 条
  • [21] Tid-1 interacts with the von Hippel-Lindau protein and modulates angiogenesis by destabilization of HIF-1α
    Bae, MK
    Jeong, JW
    Kim, SH
    Kim, SY
    Kang, HJ
    Kim, DM
    Bae, SK
    Yun, I
    Trentin, GA
    Rozakis-Adcock, M
    Kim, KW
    CANCER RESEARCH, 2005, 65 (07) : 2520 - 2525
  • [22] Inactivation of von Hippel-Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma
    Nakaigawa, N
    Yao, M
    Baba, M
    Kato, S
    Kishida, T
    Hattori, K
    Nagashima, Y
    Kubota, Y
    CANCER RESEARCH, 2006, 66 (07) : 3699 - 3705
  • [23] Role of nuclear and cytoplasmic localization in the tumour-suppressor activity of the von Hippel-Lindau protein
    Lewis, MD
    Roberts, BJ
    ONCOGENE, 2003, 22 (26) : 3992 - 3997
  • [24] The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity
    Lisztwan, J
    Imbert, G
    Wirbelauer, C
    Gstaiger, M
    Krek, W
    GENES & DEVELOPMENT, 1999, 13 (14) : 1822 - 1833
  • [25] Role of nuclear and cytoplasmic localization in the tumour-suppressor activity of the von Hippel-Lindau protein
    Martin D Lewis
    Ben J Roberts
    Oncogene, 2003, 22 : 3992 - 3997
  • [26] EXPRESSION OF HYPOXIA-INDUCIBLE FACTOR IN RENAL CELL CARCINOMA IS INDEPENDENT OF VON-HIPPEL LINDAU PROTEIN INACTIVATION
    Tanaka, Toshiaki
    Torigoe, Toshihiko
    Hirohashi, Yoshihiko
    Sato, Eiji
    Kitamura, Hiroshi
    Masumori, Naoya
    Sato, Noriyuki
    Tsukamoto, Taiji
    JOURNAL OF UROLOGY, 2009, 181 (04): : 36 - 37
  • [27] Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity
    An, JB
    Rettig, MB
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (17) : 7546 - 7556
  • [28] Regulation of Cellular Levels of Sprouty2 Protein by Prolyl Hydroxylase Domain and von Hippel-Lindau Proteins
    Anderson, Kimberly
    Nordquist, Kyle A.
    Gao, Xianlong
    Hicks, Kristin C.
    Zhai, Bo
    Gygi, Steven P.
    Patel, Tarun B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (49) : 42027 - 42036
  • [29] von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
    Hoffman, MA
    Ohh, M
    Yang, HF
    Klco, JM
    Ivan, M
    Kaelin, WG
    HUMAN MOLECULAR GENETICS, 2001, 10 (10) : 1019 - 1027
  • [30] Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation
    Ji, Qingzhou
    Burk, Robert D.
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2008, 86 (03): : 227 - 234